Skip to main content
# Title Research Member Research Year
81 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Prof. Ashraf Zeidan Abdalla Ahmed 2020
82 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Mayada Fawzy Sedik Farghaly 2020
83 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Hanaan Ahmed Mohammed Ahmed 2020
84 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Abeer Elsayed Ali Ibrahim 2020
85 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Abeer Elsayed Ali Ibrahim 2020
86 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Mayada Fawzy Sedik Farghaly 2020
87 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Salah Mabrouk Khallaf Abd Rabou 2020
88 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience)
Prof. Ashraf Zeidan Abdalla Ahmed 2020
89 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Amen Hamdy Zaki Ali 2020
90 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Rabab Mohammed Mamdouh Abdelhameed 2020